Korean J Lab Med.  2007 Dec;27(6):442-450. 10.3343/kjlm.2007.27.6.442.

Human Leukocyte Antigen Typing Proficiency Surveys in Korea, 2005-2006

  • 1Department of Laboratory Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea. hboh@amc.seoul.kr


BACKGROUND: To monitor the performance of histocompatibility testing laboratories, HLA proficiency survey in Korea has been conducted biannually since 1996. In this report, we summarized the results of the surveys performed in recent two years (2005-2006). METHODS: A total of four proficiency surveys were performed, in which 59-61 laboratories participated. Each survey included three tests for HLA class I (serology and DNA) and class II (DNA) typing and six tests for HLA crossmatch. RESULTS: The overall concordance of serologic typing was 98.9% (355/359) for HLA-A, 97.5% (350/ 359) for HLA-B, and 94.7% (337/356) for HLA-C. The antigens assigned correctly by less than 95% of the participating laboratories were A26 (93.8%), B38 (94.2%), Cw3/Cw10 (90.9%), Cw6 (94.4%), and Cw8 (74.3%). The overall concordance rates of DNA typing were 99.6% (533/535) for HLA-A, 99.8% (539/540) for HLA-B, and 100% (392/392) for HLA-C. Correct assignment of HLA-DRB1 and -DQB1 was reported by 99.2% (98.1-100%) and 96.7% (88.9-100%) for the generic level and 100% and 95.8% (75-100%) for the allelic level, respectively. On the average 3.8% (0-7.7%) of the total laboratories showed unacceptable results in the crossmatch tests. CONCLUSIONS: The rates of correct antigen identification and of unacceptable crossmatch were similar to those of previous surveys, which were considered satisfactory. The Korean proficiency survey program may have contributed to a high quality of HLA tests today and should be continued for further improvements of the tests tomorrow.


Proficiency survey; HLA typing; HLA crossmatch

MeSH Terms

Data Collection
HLA Antigens/*blood/genetics
HLA-A Antigens/blood/genetics
HLA-B Antigens/blood/genetics
HLA-C Antigens/blood/genetics
HLA-DQ Antigens/blood/genetics
HLA-DR Antigens/blood/genetics
Histocompatibility Testing/*standards
Quality Control


1.Appendix one; proficiency testing programs. ASHI laboratory manual. 2nd ed.American Society for Histocompatibility and Immunogenetics;1990. p. 693–8.
2.Shroyer TW. Proficiency testing. Nikaein A, editor. ASHI laboratory manual. 3rd ed.American Society for Histocompativility and Immunogenetics;1996. p. VI.8.1–VI.8.3.
3.Park MH. A questionnaire survey of HLA laboratories in Korea (1993). J Korean Soc Transplant. 1993. 7:245–8. (박명희. 전국 HLA 검사실 현황 설문조사(1993). 대한이식학회지 1993;7: 245-8.).
4.Park MH., Yang YS. A questionnaire survey of HLA laboratories in Korea (1995). Korean J Clin Pathol. 1996. 16:987–1000. (박명희및 양윤선. 전국 HLA 검사실 현황 설문조사(1995). 대한임상병리학회지 1996;16: 987-1000.).
5.Park MH., Whang DH. A questionnaire survey of HLA laboratories in Korea (1997). Korean J Clin Pathol. 1998. 18:650–9. (박명희 및황동희. 전국 HLA 검사실현황설문조사(1997). 대한임상병리학회지 1998;18: 650-9.).
6.Park MH., Whang DH., Kim BC. A two-year study on the HLA typing proficiency survey in Korea, 1996-1998. Korean J Clin Pathol. 1999. 19:714–22. (박명희, 황동희, 김병철. HLA 검사 신빙도조사 결과(1996-1998년). 대한임상병리학회지 1999;19: 714-22.).
7.Park MH., Kim BC., Han BY. Results of the HLA typing proficiency survey in Korea, 2000-2002. Korean J Lab Med. 2005. 25:329–39. (박명희, 김병철, 한복연. HLA 검사 신빙도조사 결과(2000-2002년). 대한진단검사의학회지 2005;25: 329-39.).
8.Lim JH., Hwang SH., Oh HB. HLA typing proficiency survey in Korea, 2003-2004. Korean J Lab Med. 2005. 25:434–41. (임지훈, 황상현, 오흥범. HLA 검사 신빙도조사 결과(2003-2004년). 대한진단검사의학회지 2005;25: 434-41.).
9.Lim JH., Hwang SH., Oh HB. A questionnaire survey of HLA laboratories in Korea (2005). Korean J Lab Med. 2005. 25:425–33. (임지훈, 황상현, 오흥범. 전국 HLA 검사실 현황 설문조사(2005). 대한진단검사의학회지 2005;25: 425-33.).
10.Neisig A., Melief CJ., Neefjes J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol. 1998. 160:171–9.
11.Neefjes JJ., Ploegh HL. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol. 1988. 18:801–10.
12.Marrari M., Duquesnoy RJ. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A, B, C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists. Hum Immunol. 1994. 39:87–95.
13.Van Kampen CA., Roelen DL., Versteeg-van der Voort Maarschalk MF., Hoitsma AJ., Allebes WA., Claas FH. Activated HLA class-I reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure. Transplantation. 2002. 74:1114–9.
14.Halloran PF., Wadgymar A., Ritchie S., Falk J., Solez K., Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation. 1990. 49:85–91.
15.Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant. 2001. 16:897–904.
16.Conca R., Pratico-Barbato L., Dall'Omo AM., Amoroso A. The Italian quality control scheme for crossmatching procedures and HLA sera screening: the 2002 pilot study. Arch Pathol Lab Med. 2005. 129:1470–5.
17.Duquesnoy RJ., Marrari M. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods. Arch Pathol Lab Med. 2003. 127:149–56.
Full Text Links
  • KJLM
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr